Company Profile

Abcombi Biosciences Inc
Profile last edited on: 6/12/2017      CAGE:       UEI: PLZSN5VT51L1

Business Identifier: Rethinking current vaccine paradigms to deliver “smarter” vaccine solutions
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

303 Furnas Hall
Buffalo, NY 14260
   (919) 619-6772
Location: Single
Congr. District: 26
County: Erie

Public Profile

Abcombi Biosciences is a pre-clinical vaccine and therapeutic development company addressing delivery of “smarter” vaccine and anti-infective solutions. Based in Buffalo but having labs space in Johnson & Johnson’s incubator, JLABs, Toronto. the firm has already developed key technologies and analytical strategies to facilitate our unique protection strategies: The firm has developed a novel biofilm model that mimics the natural progression of disease for colonizing bacteria such Streptococcus pneumoniae and Staphylococcus aureus. The plan is toengage ioinformatics in conjunction with our biofilm model to identify antigens associated with specific stages of disease progression. The firm also has crated a novel formulation strategy that removes the need for complex chemistry to produce polysaccharide conjugate vaccines and a broad RNA-based therapy for treating influenza infections.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Charles Houston Jones -- CEO

  Andrew Hill

  Chris Kilgore -- Chief Operating Officer

  Jonathan Lovell -- Founder

  Blaine Pfeifer

Company News

There are no news available.